|

Revefenacin (YUPELRI) & Formoterol (Perforomist) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 4: 1

Top Sponsors

  • University of Tennessee Graduate School of Medicine1

Indications

  • COPD Exacerbation1
  • COPD1

Knoxville, Tennessee1 trial

Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Hospitalized Patients With AECOPD

University of Tennessee Medical Center

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.